Global Adalimumab Biosimilar Market Research Report 2017

Publisher Name :
Date: 04-Oct-2017
No. of pages: 112
Inquire Before Buying

In this report, the global Adalimumab Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Adalimumab Biosimilar in these regions, from 2012 to 2022 (forecast), covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Global Adalimumab Biosimilar market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

- AET BioTech

- Amgen

- Boehringer Ingelheim

- Coherus Biosciences

- Fujifilm Kyowa Kirin Biologics

- LG Life Sciences/Mochida Pharmaceutical

- Momenta Pharmaceuticals

- Oncobiologics

- Pfizer

- Samsung Bioepsis

- Sandoz

- Zydus Cadila

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Tablet

- Oral Solution

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Adalimumab Biosimilar for each application, including

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Adalimumab Biosimilar Market Research Report 2017

Table of Contents
Global Adalimumab Biosimilar Market Research Report 2017
1 Adalimumab Biosimilar Market Overview
1.1 Product Overview and Scope of Adalimumab Biosimilar
1.2 Adalimumab Biosimilar Segment by Type (Product Category)
1.2.1 Global Adalimumab Biosimilar Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Adalimumab Biosimilar Production Market Share by Type (Product Category) in 2016
1.2.3 Tablet
1.2.4 Oral Solution
1.3 Global Adalimumab Biosimilar Segment by Application
1.3.1 Adalimumab Biosimilar Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Adalimumab Biosimilar Market by Region (2012-2022)
1.4.1 Global Adalimumab Biosimilar Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Adalimumab Biosimilar (2012-2022)
1.5.1 Global Adalimumab Biosimilar Revenue Status and Outlook (2012-2022)
1.5.2 Global Adalimumab Biosimilar Capacity, Production Status and Outlook (2012-2022)
2 Global Adalimumab Biosimilar Market Competition by Manufacturers
2.1 Global Adalimumab Biosimilar Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Adalimumab Biosimilar Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Adalimumab Biosimilar Production and Share by Manufacturers (2012-2017)
2.2 Global Adalimumab Biosimilar Revenue and Share by Manufacturers (2012-2017)
2.3 Global Adalimumab Biosimilar Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Adalimumab Biosimilar Manufacturing Base Distribution, Sales Area and Product Type
2.5 Adalimumab Biosimilar Market Competitive Situation and Trends
2.5.1 Adalimumab Biosimilar Market Concentration Rate
2.5.2 Adalimumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Adalimumab Biosimilar Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Adalimumab Biosimilar Capacity and Market Share by Region (2012-2017)
3.2 Global Adalimumab Biosimilar Production and Market Share by Region (2012-2017)
3.3 Global Adalimumab Biosimilar Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Adalimumab Biosimilar Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Adalimumab Biosimilar Consumption by Region (2012-2017)
4.2 North America Adalimumab Biosimilar Production, Consumption, Export, Import (2012-2017)
4.3 Europe Adalimumab Biosimilar Production, Consumption, Export, Import (2012-2017)
4.4 China Adalimumab Biosimilar Production, Consumption, Export, Import (2012-2017)
4.5 Japan Adalimumab Biosimilar Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Adalimumab Biosimilar Production, Consumption, Export, Import (2012-2017)
4.7 India Adalimumab Biosimilar Production, Consumption, Export, Import (2012-2017)
5 Global Adalimumab Biosimilar Production, Revenue (Value), Price Trend by Type
5.1 Global Adalimumab Biosimilar Production and Market Share by Type (2012-2017)
5.2 Global Adalimumab Biosimilar Revenue and Market Share by Type (2012-2017)
5.3 Global Adalimumab Biosimilar Price by Type (2012-2017)
5.4 Global Adalimumab Biosimilar Production Growth by Type (2012-2017)
6 Global Adalimumab Biosimilar Market Analysis by Application
6.1 Global Adalimumab Biosimilar Consumption and Market Share by Application (2012-2017)
6.2 Global Adalimumab Biosimilar Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Adalimumab Biosimilar Manufacturers Profiles/Analysis
7.1 AET BioTech
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Adalimumab Biosimilar Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AET BioTech Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Amgen
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Adalimumab Biosimilar Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Amgen Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Boehringer Ingelheim
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Adalimumab Biosimilar Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Boehringer Ingelheim Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Coherus Biosciences
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Adalimumab Biosimilar Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Coherus Biosciences Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Fujifilm Kyowa Kirin Biologics
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Adalimumab Biosimilar Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 LG Life Sciences/Mochida Pharmaceutical
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Adalimumab Biosimilar Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Momenta Pharmaceuticals
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Adalimumab Biosimilar Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Oncobiologics
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Adalimumab Biosimilar Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Oncobiologics Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Pfizer
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Adalimumab Biosimilar Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Pfizer Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Samsung Bioepsis
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Adalimumab Biosimilar Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Samsung Bioepsis Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Sandoz
7.12 Zydus Cadila
8 Adalimumab Biosimilar Manufacturing Cost Analysis
8.1 Adalimumab Biosimilar Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Adalimumab Biosimilar
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Adalimumab Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Adalimumab Biosimilar Market Forecast (2017-2022)
12.1 Global Adalimumab Biosimilar Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Adalimumab Biosimilar Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Adalimumab Biosimilar Price and Trend Forecast (2017-2022)
12.2 Global Adalimumab Biosimilar Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Adalimumab Biosimilar Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Adalimumab Biosimilar Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Adalimumab Biosimilar
Figure Global Adalimumab Biosimilar Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Adalimumab Biosimilar Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Tablet
Table Major Manufacturers of Tablet
Figure Product Picture of Oral Solution
Table Major Manufacturers of Oral Solution
Figure Global Adalimumab Biosimilar Consumption (K Units) by Applications (2012-2022)
Figure Global Adalimumab Biosimilar Consumption Market Share by Applications in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Global Adalimumab Biosimilar Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Adalimumab Biosimilar Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Adalimumab Biosimilar Major Players Product Capacity (K Units) (2012-2017)
Table Global Adalimumab Biosimilar Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Adalimumab Biosimilar Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Adalimumab Biosimilar Capacity (K Units) of Key Manufacturers in 2016
Figure Global Adalimumab Biosimilar Capacity (K Units) of Key Manufacturers in 2017
Figure Global Adalimumab Biosimilar Major Players Product Production (K Units) (2012-2017)
Table Global Adalimumab Biosimilar Production (K Units) of Key Manufacturers (2012-2017)
Table Global Adalimumab Biosimilar Production Share by Manufacturers (2012-2017)
Figure 2016 Adalimumab Biosimilar Production Share by Manufacturers
Figure 2017 Adalimumab Biosimilar Production Share by Manufacturers
Figure Global Adalimumab Biosimilar Major Players Product Revenue (Million USD) (2012-2017)
Table Global Adalimumab Biosimilar Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Adalimumab Biosimilar Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Adalimumab Biosimilar Revenue Share by Manufacturers
Table 2017 Global Adalimumab Biosimilar Revenue Share by Manufacturers
Table Global Market Adalimumab Biosimilar Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Adalimumab Biosimilar Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Adalimumab Biosimilar Manufacturing Base Distribution and Sales Area
Table Manufacturers Adalimumab Biosimilar Product Category
Figure Adalimumab Biosimilar Market Share of Top 3 Manufacturers
Figure Adalimumab Biosimilar Market Share of Top 5 Manufacturers
Table Global Adalimumab Biosimilar Capacity (K Units) by Region (2012-2017)
Figure Global Adalimumab Biosimilar Capacity Market Share by Region (2012-2017)
Figure Global Adalimumab Biosimilar Capacity Market Share by Region (2012-2017)
Figure 2016 Global Adalimumab Biosimilar Capacity Market Share by Region
Table Global Adalimumab Biosimilar Production by Region (2012-2017)
Figure Global Adalimumab Biosimilar Production (K Units) by Region (2012-2017)
Figure Global Adalimumab Biosimilar Production Market Share by Region (2012-2017)
Figure 2016 Global Adalimumab Biosimilar Production Market Share by Region
Table Global Adalimumab Biosimilar Revenue (Million USD) by Region (2012-2017)
Table Global Adalimumab Biosimilar Revenue Market Share by Region (2012-2017)
Figure Global Adalimumab Biosimilar Revenue Market Share by Region (2012-2017)
Table 2016 Global Adalimumab Biosimilar Revenue Market Share by Region
Figure Global Adalimumab Biosimilar Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Adalimumab Biosimilar Consumption (K Units) Market by Region (2012-2017)
Table Global Adalimumab Biosimilar Consumption Market Share by Region (2012-2017)
Figure Global Adalimumab Biosimilar Consumption Market Share by Region (2012-2017)
Figure 2016 Global Adalimumab Biosimilar Consumption (K Units) Market Share by Region
Table North America Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Adalimumab Biosimilar Production (K Units) by Type (2012-2017)
Table Global Adalimumab Biosimilar Production Share by Type (2012-2017)
Figure Production Market Share of Adalimumab Biosimilar by Type (2012-2017)
Figure 2016 Production Market Share of Adalimumab Biosimilar by Type
Table Global Adalimumab Biosimilar Revenue (Million USD) by Type (2012-2017)
Table Global Adalimumab Biosimilar Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Adalimumab Biosimilar by Type (2012-2017)
Figure 2016 Revenue Market Share of Adalimumab Biosimilar by Type
Table Global Adalimumab Biosimilar Price (USD/Unit) by Type (2012-2017)
Figure Global Adalimumab Biosimilar Production Growth by Type (2012-2017)
Table Global Adalimumab Biosimilar Consumption (K Units) by Application (2012-2017)
Table Global Adalimumab Biosimilar Consumption Market Share by Application (2012-2017)
Figure Global Adalimumab Biosimilar Consumption Market Share by Applications (2012-2017)
Figure Global Adalimumab Biosimilar Consumption Market Share by Application in 2016
Table Global Adalimumab Biosimilar Consumption Growth Rate by Application (2012-2017)
Figure Global Adalimumab Biosimilar Consumption Growth Rate by Application (2012-2017)
Table AET BioTech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AET BioTech Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AET BioTech Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure AET BioTech Adalimumab Biosimilar Production Market Share (2012-2017)
Figure AET BioTech Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure Amgen Adalimumab Biosimilar Production Market Share (2012-2017)
Figure Amgen Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure Boehringer Ingelheim Adalimumab Biosimilar Production Market Share (2012-2017)
Figure Boehringer Ingelheim Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table Coherus Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Coherus Biosciences Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Coherus Biosciences Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure Coherus Biosciences Adalimumab Biosimilar Production Market Share (2012-2017)
Figure Coherus Biosciences Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Market Share (2012-2017)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table LG Life Sciences/Mochida Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Market Share (2012-2017)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table Momenta Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Momenta Pharmaceuticals Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Production Market Share (2012-2017)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table Oncobiologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Oncobiologics Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Oncobiologics Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure Oncobiologics Adalimumab Biosimilar Production Market Share (2012-2017)
Figure Oncobiologics Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure Pfizer Adalimumab Biosimilar Production Market Share (2012-2017)
Figure Pfizer Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table Samsung Bioepsis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Samsung Bioepsis Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Samsung Bioepsis Adalimumab Biosimilar Production Growth Rate (2012-2017)
Figure Samsung Bioepsis Adalimumab Biosimilar Production Market Share (2012-2017)
Figure Samsung Bioepsis Adalimumab Biosimilar Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab Biosimilar
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Adalimumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2016
Table Major Buyers of Adalimumab Biosimilar
Table Distributors/Traders List
Figure Global Adalimumab Biosimilar Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Adalimumab Biosimilar Price (Million USD) and Trend Forecast (2017-2022)
Table Global Adalimumab Biosimilar Production (K Units) Forecast by Region (2017-2022)
Figure Global Adalimumab Biosimilar Production Market Share Forecast by Region (2017-2022)
Table Global Adalimumab Biosimilar Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Adalimumab Biosimilar Consumption Market Share Forecast by Region (2017-2022)
Figure North America Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Adalimumab Biosimilar Production (K Units) Forecast by Type (2017-2022)
Figure Global Adalimumab Biosimilar Production (K Units) Forecast by Type (2017-2022)
Table Global Adalimumab Biosimilar Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share Forecast by Type (2017-2022)
Table Global Adalimumab Biosimilar Price Forecast by Type (2017-2022)
Table Global Adalimumab Biosimilar Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Adalimumab Biosimilar Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • United States Adalimumab Biosimilar Market Report 2017
    Published: 17-Oct-2017        Price: US 3800 Onwards        Pages: 111
    In this report, the United States Adalimumab Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ra......
  • Global Biologics and Biosimilars Market Professional Survey Report 2017
    Published: 16-Oct-2017        Price: US 3500 Onwards        Pages: 112
    This report studies Biologics and Biosimilars in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Pfizer - Roche - Amgen - AbbVie - Sanofi - J......
  • Global Adalimumab Biosimilar Sales Market Report 2017
    Published: 13-Oct-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the global Adalimumab Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Adalimumab Biosimilar for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe ......
  • The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis
    Published: 13-Oct-2017        Price: US 4000 Onwards        Pages: 104
    The U.S. psoriasis treatment market for Biologics and Biosimilars was estimated at $6.6bn in 2016 is projected to almost double during the forecast period to reach $12.9bn in 2021 driven by safety and efficacy improvements of the new generation biologics. The psoriasis treatment market is dominated by topical agents and photo therapy for the non-severe forms (mainly corticosteroids), but mild to severe forms are treated with systemic agents. The psoriasis treatment market is dominated......
  • United States Oncology Biosimilars Market Report 2017
    Published: 03-Oct-2017        Price: US 3800 Onwards        Pages: 104
    In this report, the United States Oncology Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rat......
  • Global Oncology Biosimilars Sales Market Report 2017
    Published: 28-Sep-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the global Oncology Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Oncology Biosimilars for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • United States Biologics and Biosimilars Market Report 2017
    Published: 22-Sep-2017        Price: US 3800 Onwards        Pages: 113
    In this report, the United States Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growt......
  • Global Biologics and Biosimilars Sales Market Report 2017
    Published: 19-Sep-2017        Price: US 4000 Onwards        Pages: 119
    In this report, the global Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biologics and Biosimilars for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Oncology Biosimilars Market Research Report 2017
    Published: 18-Sep-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Oncology Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oncology Biosimilars in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs